{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:09:22Z","timestamp":1776056962833,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00330-015-3900-3","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T21:13:53Z","timestamp":1437426833000},"page":"921-931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents"],"prefix":"10.1007","volume":"26","author":[{"given":"E.","family":"Neri","sequence":"first","affiliation":[]},{"given":"M. A.","family":"Bali","sequence":"additional","affiliation":[]},{"given":"A.","family":"Ba-Ssalamah","sequence":"additional","affiliation":[]},{"given":"P.","family":"Boraschi","sequence":"additional","affiliation":[]},{"given":"G.","family":"Brancatelli","sequence":"additional","affiliation":[]},{"given":"F. Caseiro","family":"Alves","sequence":"additional","affiliation":[]},{"given":"L.","family":"Grazioli","sequence":"additional","affiliation":[]},{"given":"T.","family":"Helmberger","sequence":"additional","affiliation":[]},{"given":"J. M.","family":"Lee","sequence":"additional","affiliation":[]},{"given":"R.","family":"Manfredi","sequence":"additional","affiliation":[]},{"given":"L.","family":"Mart\u00ec-Bonmat\u00ec","sequence":"additional","affiliation":[]},{"given":"C.","family":"Matos","sequence":"additional","affiliation":[]},{"given":"E. M.","family":"Merkle","sequence":"additional","affiliation":[]},{"given":"B.","family":"Op De Beeck","sequence":"additional","affiliation":[]},{"given":"W.","family":"Schima","sequence":"additional","affiliation":[]},{"given":"S.","family":"Skehan","sequence":"additional","affiliation":[]},{"given":"V.","family":"Vilgrain","sequence":"additional","affiliation":[]},{"given":"C.","family":"Zech","sequence":"additional","affiliation":[]},{"given":"C.","family":"Bartolozzi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"3900_CR1","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s00330-003-1912-x","volume":"13","author":"MF Bellin","year":"2003","unstructured":"Bellin MF, Vasile M, Morel-Precetti S (2003) Currently used non-specific extracellular MR contrast media. Eur Radiol 13:2688\u20132698","journal-title":"Eur Radiol"},{"key":"3900_CR2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.rcl.2005.05.004","volume":"43","author":"NC Balci","year":"2005","unstructured":"Balci NC, Semelka RC (2005) Contrast agents for MR imaging of the liver. Radiol Clin N Am 43:887\u2013898","journal-title":"Radiol Clin N Am"},{"key":"3900_CR3","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1148\/rg.296095516","volume":"29","author":"SM Erturk","year":"2009","unstructured":"Erturk SM, Alberich-Bayarri A, Herrmann KA, Marti-Bonmati L, Ros PR (2009) Use of 3.0-T MR imaging for evaluation of the abdomen. Radiographics 29:1547\u20131563","journal-title":"Radiographics"},{"key":"3900_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000333265","volume":"81","author":"M Kudo","year":"2011","unstructured":"Kudo M (2011) Diagnostic imaging of hepatocellular carcinoma: recent progress. Oncology 81:73\u201385","journal-title":"Oncology"},{"key":"3900_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2214\/AJR.12.9491","volume":"201","author":"CJ Zech","year":"2013","unstructured":"Zech CJ, Bartolozzi C, Bioulac-Sage P et al (2013) Consensus report of the fifth international forum for liver MRI. AJR Am J Roentgenol 201:97\u2013107","journal-title":"AJR Am J Roentgenol"},{"key":"3900_CR6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1148\/radiol.14132361","volume":"272","author":"JY Choi","year":"2014","unstructured":"Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635\u2013654, reviewer 2, comment 24","journal-title":"Radiology"},{"key":"3900_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(24)34879-7","volume":"290","author":"JE Montfoort van","year":"1999","unstructured":"van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290:153\u2013157","journal-title":"J Pharmacol Exp Ther"},{"key":"3900_CR8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1148\/rg.296095515","volume":"29","author":"MK Seale","year":"2009","unstructured":"Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725\u20131748","journal-title":"Radiographics"},{"key":"3900_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1148\/radiology.218.1.r01ja2427","volume":"218","author":"RC Semelka","year":"2001","unstructured":"Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 218:27\u201338","journal-title":"Radiology"},{"key":"3900_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2214\/AJR.10.4392","volume":"195","author":"KI Ringe","year":"2010","unstructured":"Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium\u2013enhanced MRI of the liver: Part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR 195:13\u201328","journal-title":"AJR"},{"key":"3900_CR11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1148\/rg.316115528","volume":"31","author":"MD Goodwin","year":"2011","unstructured":"Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. RadioGraphics 31:1547\u20131568","journal-title":"RadioGraphics"},{"key":"3900_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","volume":"57","author":"BE Beers Van","year":"2012","unstructured":"Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421\u2013429","journal-title":"J Hepatol"},{"key":"3900_CR13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.rcl.2014.02.004","volume":"52","author":"FF Guglielmo","year":"2014","unstructured":"Guglielmo FF, Mitchell DG, Gupta S (2014) Gadolinium contrast agent selection and optimal use for body MR imaging. Radiol Clin N Am 52:637\u2013656","journal-title":"Radiol Clin N Am"},{"key":"3900_CR14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bpg.2014.08.005","volume":"28","author":"M Ronot","year":"2014","unstructured":"Ronot M, Vilgrain V (2014) Hepatocellular carcinoma: diagnostic criteria by imaging techniques. Best Pract Res Clin Gastroenterol 28:795\u2013812","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"3900_CR15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.rcl.2014.02.005","volume":"52","author":"JR Cogley","year":"2014","unstructured":"Cogley JR, Miller FH (2014) MR imaging of benign focal liver lesions. Radiol Clin N Am 52:657\u2013682","journal-title":"Radiol Clin N Am"},{"key":"3900_CR16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.rcl.2014.02.016","volume":"52","author":"TA Hope","year":"2014","unstructured":"Hope TA, Ohliger MA, Qayyum A (2014) MR imaging of diffuse liver disease: from technique to diagnosis. Radiol Clin N Am 52:709\u2013724","journal-title":"Radiol Clin N Am"},{"key":"3900_CR17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0895-4356(03)00211-7","volume":"56","author":"B Graham","year":"2003","unstructured":"Graham B, Regehr G, Wright JG (2003) Delphi as a method to establish consensus for diagnostic criteria. J Clin Epidemiol 56:1150\u20131156","journal-title":"J Clin Epidemiol"},{"key":"3900_CR18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383\u2013394","journal-title":"J Clin Epidemiol"},{"key":"3900_CR19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0895-4356(91)90076-L","volume":"44","author":"G Bravo","year":"1991","unstructured":"Bravo G, Potvin L (1991) Estimating the reliability of continuous measures with Cronbach's alpha or the intraclass correlation coefficient: toward the integration of two traditions. J Clin Epidemiol 44:381\u2013390","journal-title":"J Clin Epidemiol"},{"key":"3900_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02313422","volume":"16","author":"L Cronbach","year":"1951","unstructured":"Cronbach L (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:3","journal-title":"Psychometrika"},{"key":"3900_CR21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.mric.2007.06.003","volume":"15","author":"M Ramalho","year":"2007","unstructured":"Ramalho M, Altun E, Her\u00e9dia V, Zapparoli M, Semelka R (2007) Liver MR imaging: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15:321\u2013347","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"3900_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mric.2005.12.001","volume":"14","author":"EM Merkle","year":"2006","unstructured":"Merkle EM, Dale BM, Paulson EK (2006) Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am 14:17\u201326","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"3900_CR23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1148\/radiol.2411051221","volume":"241","author":"MM Falkenhausen von","year":"2006","unstructured":"von Falkenhausen MM, Lutterbey G, Morakkabati-Spitz N et al (2006) High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T. Radiology 241:156\u2013166 (reviewer 2, comment 15)","journal-title":"Radiology"},{"key":"3900_CR24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.rli.0000192417.33989.7a","volume":"41","author":"JM Chang","year":"2006","unstructured":"Chang JM, Lee JM, Lee MW et al (2006) Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions. Investig Radiol 41:168\u2013174 (reviewer 2, comment 15)","journal-title":"Investig Radiol"},{"key":"3900_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2214\/AJR.11.7757","volume":"199","author":"RT Gupta","year":"2012","unstructured":"Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B (2012) Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. AJR Am J Roentgenol 199:35\u201343 (reviewer 4, comment 2)","journal-title":"AJR Am J Roentgenol"},{"key":"3900_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jmri.22262","volume":"32","author":"AR Karam","year":"2010","unstructured":"Karam AR, Shankar S, Surapaneni P, Kim YH, Hussain S (2010) Focal nodular hyperplasia: central scar enhancement pattern using gadoxetate disodium. J Magn Reson Imaging 32:341\u2013344 (reviewer 4, comment 2)","journal-title":"J Magn Reson Imaging"},{"key":"3900_CR27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3348\/kjr.2010.11.4.433","volume":"11","author":"Y Park","year":"2010","unstructured":"Park Y, Kim SH, Kim SH et al (2010) Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience. Korean J Radiol 11:433\u2013440 (reviewer 4, comment 2)","journal-title":"Korean J Radiol"},{"key":"3900_CR28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3350\/cmh.2013.19.4.360","volume":"19","author":"WK Jeong","year":"2013","unstructured":"Jeong WK, Kim YK, Song KD, Choi D, Lim HK (2013) The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase. Clin Mol Hepatol 19:360\u2013366 (reviewer 2, comment 24)","journal-title":"Clin Mol Hepatol"},{"key":"3900_CR29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jmri.23874","volume":"37","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kim BS, Kim MJ et al (2013) Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate. Reson Imaging 37:903\u2013938 (reviewer 2, comment 24)","journal-title":"Reson Imaging"},{"key":"3900_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1586\/17474124.2014.876359","volume":"8","author":"A Ba-Ssalamah","year":"2014","unstructured":"Ba-Ssalamah A, Qayyum A, Bastati N, Fakhrai N, Herold CJ, Caseiro Alves F (2014) P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker. Expert Rev Gastroenterol Hepatol 8:147\u2013160","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3900_CR31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.11101742","volume":"262","author":"L Grazioli","year":"2012","unstructured":"Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520\u2013529","journal-title":"Radiology"},{"key":"3900_CR32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiol.2361040338","volume":"236","author":"L Grazioli","year":"2005","unstructured":"Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenatedimeglumine-enhanced MR imaging: prospective study. Radiology 236:166\u2013177 (reviewer 4, comment 4)","journal-title":"Radiology"},{"key":"3900_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2342-13-41","volume":"13","author":"M Haimerl","year":"2013","unstructured":"Haimerl M, W\u00e4chtler M, Platzek I et al (2013) Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions. BMC Med Imaging 13:41 (reviewer 2, comment 24)","journal-title":"BMC Med Imaging"},{"key":"3900_CR34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/RLI.0b013e3181feee3a","volume":"46","author":"G Morana","year":"2011","unstructured":"Morana G, Grazioli L, Kirchin MA et al (2011) Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenatedimeglumine administration. Investig Radiol 46:225\u2013239 (reviewer 4, comment 5)","journal-title":"Investig Radiol"},{"key":"3900_CR35","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00330-013-2824-z","volume":"23","author":"M Scharitzer","year":"2013","unstructured":"Scharitzer M, Ba-Ssalamah A, Ringl H, K\u00f6lblinger C, Gr\u00fcnberger T, Weber M, Schima W (2013) Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol 23:2187\u20132196","journal-title":"Eur Radiol"},{"key":"3900_CR36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1259\/bjr\/25139667","volume":"85","author":"YK Kim","year":"2012","unstructured":"Kim YK, Park G, Kim CS, Yu HC, Han YM (2012) Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT. Br J Radiol 85:539\u2013547","journal-title":"Br J Radiol"},{"key":"3900_CR37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.13131810","volume":"271","author":"NY Han","year":"2014","unstructured":"Han NY, Park BJ, Sung DJ et al (2014) Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid\u2013enhanced and diffusion-weighted MR Imaging with clinical-pathologic correlation. Radiology 271:416\u2013425","journal-title":"Radiology"},{"key":"3900_CR38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejrad.2012.10.010","volume":"82","author":"AR P\u00e9port\u00e9","year":"2013","unstructured":"P\u00e9port\u00e9 AR, Sommer WH, Nikolaou K, Reiser MF, Zech CJ (2013) Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 82:101\u2013106","journal-title":"Eur J Radiol"},{"key":"3900_CR39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00261-012-9943-x","volume":"38","author":"HJ Park","year":"2013","unstructured":"Park HJ, Kim YK, Park MJ, Lee WJ (2013) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 38:793\u2013801","journal-title":"Abdom Imaging"},{"key":"3900_CR40","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ejrad.2013.05.033","volume":"82","author":"N Verloh","year":"2013","unstructured":"Verloh N, Haimerl M, Rennert J et al (2013) Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla. Eur J Radiol 82:1710\u20131715","journal-title":"Eur J Radiol"},{"key":"3900_CR41","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.3748\/wjg.v19.i45.8357","volume":"19","author":"S Phongkitkarun","year":"2013","unstructured":"Phongkitkarun S, Limsamutpetch K, Tannaphai P, Jatchavala J (2013) Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. World J Gastroenterol 19:8357\u20138365","journal-title":"World J Gastroenterol"},{"key":"3900_CR42","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/srep05621","volume":"4","author":"M Haimerl","year":"2014","unstructured":"Haimerl M, Verloh N, Fellner C et al (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621","journal-title":"Sci Rep"},{"key":"3900_CR43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00330-014-3108-y","volume":"24","author":"N Verloh","year":"2014","unstructured":"Verloh N, Haimerl M, Zeman F et al (2014) Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol 24:1013\u20131019","journal-title":"Eur Radiol"},{"key":"3900_CR44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/RCT.0b013e3181e1a88e","volume":"34","author":"L Cereser","year":"2010","unstructured":"Cereser L, Furlan A, Bagatto D et al (2010) Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 34:706\u2013711 (reviewer 4, comment 3)","journal-title":"J Comput Assist Tomogr"},{"key":"3900_CR45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00261-012-9952-9","volume":"38","author":"C Bartolozzi","year":"2013","unstructured":"Bartolozzi C, Battaglia V, Bargellini I et al (2013) Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 38:290\u2013296","journal-title":"Abdom Imaging"},{"key":"3900_CR46","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1148\/radiol.14131996","volume":"271","author":"MH Yu","year":"2014","unstructured":"Yu MH, Kim JH, Yoon JH et al (2014) Small (\u22641-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Radiology 271:748\u2013760","journal-title":"Radiology"},{"key":"3900_CR47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/apt.12166","volume":"37","author":"A Granito","year":"2013","unstructured":"Granito A, Galassi M, Piscaglia F et al (2013) Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 37:355\u2013363 (reviewer 3, comment 5)","journal-title":"Aliment Pharmacol Ther"},{"key":"3900_CR48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.mri.2010.10.013","volume":"29","author":"K Kitajima","year":"2011","unstructured":"Kitajima K, Yoshikawa T, Seo Y et al (2011) A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings. Magn Reson Imaging 29:579\u2013583","journal-title":"Magn Reson Imaging"},{"key":"3900_CR49","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00330-011-2333-x","volume":"22","author":"NY Shin","year":"2012","unstructured":"Shin NY, Kim MJ, Lim JS et al (2012) Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 22:864\u2013871","journal-title":"Eur Radiol"},{"key":"3900_CR50","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1148\/rg.296095501","volume":"29","author":"NK Lee","year":"2009","unstructured":"Lee NK, Kim S, Lee JW et al (2009) Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 29:1707\u20131724","journal-title":"Radiographics"},{"key":"3900_CR51","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00261-013-0007-7","volume":"38","author":"P Boraschi","year":"2013","unstructured":"Boraschi P, Donati F (2013) Biliary-enteric anastomoses: spectrum of findings on Gd-EOB-DTPA-enhanced MR cholangiography. Abdom Imaging 38:1351\u20131359","journal-title":"Abdom Imaging"},{"key":"3900_CR52","doi-asserted-by":"crossref","first-page":"11080","DOI":"10.3748\/wjg.v20.i32.11080","volume":"20","author":"P Boraschi","year":"2014","unstructured":"Boraschi P, Donati F (2014) Postoperative biliary adverse events following orthotopic liver transplantation: assessment with magnetic resonance cholangiography. World J Gastroenterol 20:11080\u201311094","journal-title":"World J Gastroenterol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-015-3900-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-3900-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-3900-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:21:15Z","timestamp":1748524875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-015-3900-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3900"],"URL":"https:\/\/doi.org\/10.1007\/s00330-015-3900-3","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}